Equities

Viemed Healthcare Inc

Viemed Healthcare Inc

Actions
Health CareHealth Care Providers
  • Price (USD)8.65
  • Today's Change-0.10 / -1.14%
  • Shares traded132.54k
  • 1 Year change+8.40%
  • Beta1.4681
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).

  • Revenue in USD (TTM)214.30m
  • Net income in USD10.43m
  • Incorporated2016
  • Employees996.00
  • Location
    Viemed Healthcare Inc625 E. KALISTE SALOOM RD.LAFAYETTE 70508United StatesUSA
  • Phone+1 (337) 504-3802
  • Fax+1 (337) 500-1972
  • Websitehttps://www.viemed.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
VMD:NAQ since
announced
Transaction
value
East Alabama HomeMed LLCDeal completed01 Apr 202401 Apr 2024Deal completed-8.27%--
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Joint Corp120.80m-16.86m176.21m444.00--8.59--1.46-1.14-1.148.101.371.36--30.39272,062.20-18.924.32-30.066.0590.7090.28-13.953.68--1,593.990.0022--16.2426.27-1,656.09--35.09--
Nutex Health Inc292.00m-41.13m178.93m800.00--2.84--0.6128-8.93-8.9360.2011.590.636190.724.82365,000.50-7.06-69.35-8.65-84.8523.2410.97-11.10-102.851.741.440.7824--12.93428.2289.22------
Biodesix Inc65.56m-43.82m186.20m217.00--6.68--2.84-0.3941-0.39410.56630.19150.6918--9.49302,129.00-46.24-55.60-60.89-80.9477.7259.53-66.84-105.15---3.910.5647--28.4619.1620.32--106.31--
American Oncology Network Inc1.59bn-14.57m187.01m1.53k------0.1174-1.72-1.7294.45-2.424.0434.6411.681,044,447.00-13.15------5.27---3.26--1.11-9.600.6406--11.27----------
ModivCare Inc2.79bn-183.04m254.11m21.20k------0.0912-12.87-12.87196.11-1.191.63--8.07131,491.50-10.35-1.36-15.25-1.8315.5217.58-6.34-0.9619--0.27531.01--9.8514.71-542.83--19.27--
Accolade Inc441.03m-80.10m297.99m2.40k--0.7029--0.6757-1.03-1.035.695.260.5477--17.46183,761.70-9.95-24.80-11.44-29.0448.2445.56-18.16-56.43----0.3308--14.0934.3078.29--31.97--
Viemed Healthcare Inc214.30m10.43m340.69m996.0034.052.739.601.590.2570.2575.283.211.3418.969.53215,161.606.5612.288.4015.5260.2862.574.8810.091.199.020.04890.0031.8223.2164.631.5033.67--
Enhabit Inc1.04bn-116.60m380.15m10.80k--0.6717--0.3665-2.32-2.3220.6511.250.7529--6.5196,037.04-8.28---9.49--48.79---11.00----0.66080.468---2.32---99.26------
Airsculpt Technologies Inc188.78m-7.79m405.18m346.00--4.90109.012.15-0.1373-0.13733.271.430.9156--52.88545,606.90-3.78---4.24--64.98---4.13----1.980.4594--16.07--69.49------
DocGo Inc694.97m30.83m433.71m2.92k14.971.339.390.62410.2840.2846.413.191.52--3.15238,411.106.35--8.97--34.50--4.17----61.050.1194--41.72---80.17------
Sonida Senior Living Inc278.12m-16.60m473.51m2.62k--6.1119.931.70-2.13-2.1322.486.750.3903--26.74106,272.50-1.64-6.63-1.90-8.19-----4.20-18.04---0.19160.8163--7.08-11.1155.74---3.97--
Community Health Systems Inc12.55bn-398.00m507.16m61.00k----2.210.0404-3.00-3.0095.32-13.120.87846.085.97205,770.50-1.740.7566-2.150.938184.6083.69-1.980.93451.320.98341.12--2.28-2.47-389.13---2.39--
Data as of Nov 25 2024. Currency figures normalised to Viemed Healthcare Inc's reporting currency: US Dollar USD

Institutional shareholders

40.49%Per cent of shares held by top holders
HolderShares% Held
Thrivent Asset Management LLCas of 30 Sep 20243.43m8.82%
BlackRock Fund Advisorsas of 30 Sep 20242.34m6.02%
Wasatch Advisors LPas of 30 Sep 20241.85m4.76%
The Vanguard Group, Inc.as of 31 Oct 20241.77m4.57%
Forager Capital Management LLCas of 30 Sep 20241.72m4.42%
Kent Lake PR LLCas of 30 Sep 20241.30m3.35%
Nantahala Capital Management LLCas of 30 Sep 20241.14m2.92%
Punch & Associates Investment Management, Inc.as of 30 Sep 2024796.03k2.05%
Geode Capital Management LLCas of 30 Sep 2024772.81k1.99%
AWM Investment Co., Inc.as of 30 Sep 2024612.89k1.58%
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.